Wilex AG Muenchen


By |


Heidelberg Pharma AG is a biopharmaceutical company. It is focused on oncology and develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform and advances the biological mode of action of the toxin as a novel therapeutic principle. The proprietary lead candidate is HDP-101 which is a BCMA (B-cell maturation antigen) - ATAC for multiple myeloma. In addition, the company offers preclinical contract research services.

Contact Information

Website: www.heidelberg-pharma.com
Email: investors@wilex.com
Main Phone: +49 620310090
Address: Schriesheimer Street 101
City / Town: Ladenburg
Country: DEU
Postal Code: 68526

Issuer Information

Exchange: GREY
Employees: 54
NAICS: Biological Produ
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume 0 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 28,129,129.00 EPS (TTM) -0.78 PE Ratio N/A Exchange Greys